Tabrecta

Indicated For

non-small cell lung cancer

About This Medication

# Novartis Patient Assistance Foundation Guide: How to Get Tabrecta at Low or No Cost ## About This Program If you've been prescribed Tabrecta (capmatinib) to treat non-small cell lung cancer and are struggling to afford your medication, the **Novartis Patient Assistance Foundation** may be able to help. This program provides eligible patients with Tabrecta at reduced cost or completely free of charge. Tabrecta is a targeted cancer medication that works as a MET inhibitor, designed specifically to help patients whose tumors have certain MET mutations. Because cancer medications can be expensive, Novartis created this assistance program to ensure that cost doesn't prevent you from accessing the treatment your doctor has prescribed. ## Who Can Apply? You may be eligible for assistance if you meet these general criteria: - You have a valid prescription for Tabrecta from your doctor - You are a U.S. resident - Your household income falls within the program's limits (see income table below) - You are either uninsured OR cannot afford your medication despite having insurance - You do NOT have coverage through Medicare, Medicaid, VA, or other federal/state health care programs (these patients should explore other options) **Important:** This copay assistance program is specifically for uninsured patients or those who cannot afford their out-of-pocket costs. If you have Medicare, Medicaid, or state health insurance, you may not qualify for this particular program, but other options may be available to you. ## Income Eligibility Your household income must not exceed the limits shown below. "Household" includes you, your spouse (if applicable), and any dependents you support. | Household Size | Maximum Annual Income | |---|---| | 1 person | Varies by program | | 2 people | Varies by program | | 3 people | Varies by program | | 4 people | Varies by program | | 5+ people | Varies by program | **Note:** Income limits vary and may be adjusted periodically. During your application, Novartis will provide you with current income thresholds. Generally, the program uses federal poverty guidelines as a reference, often allowing income up to 400% of the federal poverty level. ## What Documents You'll Need Before you start your application, gather these documents: 1. **A valid prescription** for Tabrecta from your oncologist 2. **Proof of residency** (utility bill, lease agreement, or government-issued ID showing your current address) 3. **Proof of income** (recent pay stubs, tax returns, Social Security statements, or unemployment documentation) 4. **Insurance information** (if you have any coverage, or a statement that you are uninsured) 5. **Photo ID** for verification purposes Having these ready will speed up your application process. ## How to Apply: Step-by-Step Instructions ### Step 1: Visit the Program Website Go to **https://pap.novartis.com** to access the application portal. You can apply online through their digital system. ### Step 2: Choose Your Application Method Novartis offers multiple ways to apply: - **Online application:** Complete the form directly on their website - **Phone application:** Call to speak with a representative who can guide you through the process - **Mail application:** Request a paper form and send it with your supporting documents Choose whichever method feels most comfortable for you. ### Step 3: Complete the Application Form You'll need to provide: - Your personal information (name, address, date of birth) - Your household size and annual income - Details about your insurance status - Your prescription and doctor's information - Your pharmacy information (so they can ship your medication directly) ### Step 4: Gather and Submit Supporting Documents Attach copies (not originals) of your proof of residency, proof of income, and prescription to your application. ### Step 5: Submit Your Application If applying online, submit through the website portal. If applying by mail, include all documents in an envelope addressed to Novartis Patient Assistance Foundation at the address provided on their website. ### Step 6: Wait for Approval Novartis will review your application and contact you with a decision. ## Timeline and Delivery **Processing Time:** Most applications are reviewed within **4 weeks** of submission. Some may be processed faster if all required documents are included and clear. **How You'll Receive Your Medication:** Once approved, Tabrecta will be **shipped directly to you** at your home address or to your pharmacy, depending on program procedures. You won't need to pick it up in person. **Notification:** Novartis will contact you by phone or mail to inform you of the approval decision and provide information about how your medication will be delivered. ## Annual Reauthorization Required This assistance is not permanent. You will need to **reauthorize your eligibility annually**. Novartis will notify you when it's time to renew. The reauthorization process is usually simpler than the initial application—you'll need to update your income information and confirm that your circumstances haven't changed significantly. ## Savings Card Option Even if you don't qualify for the full patient assistance program, **a manufacturer savings card may be available**. This card can help reduce your out-of-pocket costs for Tabrecta. Check the Novartis website at **https://pap.novartis.com** for current savings card programs and eligibility requirements. A savings card may work alongside your insurance copay. ## What If Your Application Is Denied? If Novartis determines you don't qualify for this specific program, don't lose hope. You have other options: - **Ask your doctor's office:** Many oncology practices have financial counselors who know about other assistance programs, clinical trials, or manufacturer programs you might qualify for - **Explore state programs:** Your state may have pharmaceutical assistance programs with different income limits - **Contact NeedyMeds.org:** This free resource lists hundreds of assistance programs by medication - **Look into cancer organizations:** Groups like the American Cancer Society, CancerCare, and Patient Advocate Foundation offer financial assistance for cancer patients - **Investigate clinical trials:** Some clinical trials provide free medication to participants ## Insurance Considerations **If you have Medicare or Medicaid:** You generally do not qualify for this copay assistance program (federal law restricts manufacturer assistance for these populations). However, your insurance should help cover Tabrecta. Talk to your doctor about whether prior authorization is needed, and contact your insurance company about your coverage and copay amounts. **If you have private insurance:** If you cannot afford your copay or coinsurance even with coverage, you may qualify for Novartis assistance. Be prepared to provide your insurance information. **If you're uninsured:** This program is designed for you. Proceed with the application as described above. ## Important Legal Information This patient assistance program is provided by Novartis Pharmaceuticals Corporation through the Novartis Patient Assistance Foundation. Eligibility requirements, income thresholds, and program details are subject to change. This guide provides general information and should not be considered legal or medical advice. Always consult your healthcare provider and review the official program documentation at https://pap.novartis.com for the most current and complete information. Patient assistance is intended to supplement, not replace, insurance coverage or other payment resources. Novartis reserves the right to modify or terminate this program. ## Need Help? If you have questions about the application process: - Visit **https://pap.novartis.com** for the most current information - Speak with your oncology clinic's financial counselor or social worker - Contact Novartis directly through their website - Ask your pharmacist—they often have experience with assistance programs Remember, applying for financial assistance is nothing to be embarrassed about. This program exists specifically to help patients like you access the medications your doctor has prescribed.

Program information last verified: March 25, 2026